The Intestinal Epithelium Organoid Cultures
- Challenges in establishing long-term systems for intestinal epithelium cultures
- Establishment of long-term gastrointestinal epithelium organoid culture
- The use of small molecules in intestinal organoid culture
- Building of gut organoids
- Cytokines used in long-term gastrointestinal epithelium culture
- Small molecules and peptides used in gastrointestinal culture
Challenges in establishing long-term systems for intestinal epithelium cultures
Establishment of long-term gastrointestinal epithelium organoid culture
1. Intestinal epithelium organoid cultures
- The ability to source normal epithelial cell lines from the stem cells found in the base of intestinal crypts has allowed for the establishment of long-term systems for intestinal epithelium cultures.
-
-
- This advancement has allowed for the exploitation of stem cells in tissue regenerative therapies, and the development of treatment models targeting degenerative disorders of the digestive tract.
-
- The model for a robust, long-term small intestinal epithelium organoid culture system was developed in 2009 [1].
-
- Lgr5+ stem cells isolated from murine crypts were cultured with ROCK inhibitor (Y-27632) and the ENR growth factor bundle of EGF (Epidermal Growth Factor), Noggin, and R-Spondin-1.
- This culture system mimics normal intestinal epithelial growth and differentiation and can maintain these characteristics for more than eight months.
-
2. Human small intestinal epithelium and human colonic epithelial organoid cultures
- Subsequently, a protocol for long-term organoid culturing of the human small intestinal epithelium, and both murine and human colonic epithelia was established.
-
-
- This system added the necessary signalling protein Wnt-3a to the above-mentioned ENR growth factor bundle (WENR).
-
3. Human small intestinal and colonic crypt organoid cultures
- In the case of human small intestinal and colonic crypt cultures, the further addition of p38 MAPK inhibitor (SB202190) and TGF-β inhibitor (A 83-01) was required [2].
- Currently, these protocols are routinely used in studies involving human or mouse intestinal crypt cultures [3, 4].
4. Long-term gastric gland and human small intestinal epithelium organoid cultures
- The addition of FGF-10 (Fibroblast Growth Factor-10) to the WENR bundle (WENRF) allowed researchers to establish long-term gastric gland and human small intestinal epithelium cultures [5,6,7,8].
The use of small molecules in intestinal organoid cultures
Building of gut organoids
- These gut organoids expanded from healthy, human small intestinal crypts on extracellular matrix, with the assistance of the ENR growth factor bundle, plus Wnt-3a, Y-27632, Gastrin, Nicotinamide, A 83-01, SB 202190 and LY2157299 [12].
Cytokines used in long-term gastrointestinal epithelium culture
EGF
Noggin
R-Spondin-1
Wnt-3a
FGF-10
Small molecules and peptides used in gastrointestinal culture
A-83-01
LY2157299
Y-27632 Dihydrochloride
CHIR 99021
Gastrin I
SB202190
IWP-2
Nicotinamide
Our brands
[Poster] Reagents for Organoid Research
[Brochure] Facilitate your research on Gastrointestinal Epithelium Cells with Organoid Cultures
[Brochure] Organoids - Mini organ in a dish
[Brochure] Building Blocks for Organoid Research
References:
1. Sato, T, et al. (2009) “Single Lgr5 stem cells build crypt villus structures in vitro without a mesenchymal niche.” Nature 459.7244: 262-265. 2. Sato, T, et al. (2011) “Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium.” Gastroenterology 141.5: 1762-1772. 3. Schwank, G, et al. (2013) “Generation of BAC transgenic epithelial organoids.” PloS One 8.10: e76871. 4. Grabinger, T, et al. (2014) “Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy.” Cell death & disease 5.5: e1228. 5. Lahar, N, et al. (2011) “Intestinal subepithelial myofibroblasts support in vitro and in vivo growth of human small intestinal epithelium.”PLoS One 6.11: e26898. 6. Jabaji, Z, et al. (2014) “Type I collagen as an extracellular matrix for the in vitro growth of human small intestinal epithelium.” PloS One 9.9: e107814. 7. Barker, N, et al. (2010) “Lgr5+ ve stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro.” Cell Stem Cell 6.1: 25-36. 8. Stange, D, et al. (2013) “Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium.” Cell 155.2: 357-368. 9. Koo, B-K, and Clevers, H, (2014) “Stem cells marked by the R-spondin receptor LGR5.” Gastroenterology 147.2: 289-302. 10. Cramer, J, et al. (2015) “Distinct human stem cell populations in small and large intestine.” PloS One 10.3: e0118792. 11. Farin, H. F., Van Es, J. H., & Clevers, H. (2012) “Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells.” Gastroenterology 143.6: 1518-1529. 12. Schweinlin, M, et al. (2016). “Development of an advanced primary human in vitro model of the small intestine.” Tissue Engineering Part C: Methods
13.Peprotech. (n.d.). Facilitate your research on Gastrointestinal Epithelium Cells with Organoid Cultures. Retrieved November 16, 2021, from https://www.peprotech.com/download/2024.
PeproTech and Biogems products are for research use only and are not for therapeutic or diagnostic use.